Trial Profile
Non-interventional Study to Assess the Safety Profile of Idelalisib in Patients With Refractory Follicular Lymphoma (FL)
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 23 Jan 2019
At a glance
- Drugs Idelalisib (Primary)
- Indications Follicular lymphoma
- Focus Adverse reactions
- Acronyms ZEUS
- Sponsors Gilead Sciences
- 02 Jul 2018 New trial record